Genentech, Inc.: 26 Drugs and 440,155 Adverse Event Reports
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Genentech, Inc. manufactures 26 drugs with a combined 440,155 adverse event reports in the FDA FAERS database. Their most reported drug is RITUXIMAB.
26
Drugs
440,155
Combined Reports
Top Drug
53,745
Total Deaths
115,728
Total Hospitalizations
All Genentech, Inc. Drugs & Safety Profiles
| Drug | Brand Name | Reports | Deaths | Death Rate | Hosp. |
|---|---|---|---|---|---|
| RITUXIMAB | Rituxan | 178,614 | 28,910 | 16.2% | 54,631 |
| SOMATROPIN | Nutropin AQ NuSpin 10 | 68,384 | 1,350 | 2.0% | 4,957 |
| OCRELIZUMAB | OCREVUS | 56,186 | 1,406 | 2.5% | 10,364 |
| ATEZOLIZUMAB | Tecentriq Hybreza | 33,703 | 8,520 | 25.3% | 15,094 |
| PERTUZUMAB | PERJETA | 21,995 | 2,161 | 9.8% | 7,803 |
| OBINUTUZUMAB | Gazyva | 14,189 | 1,919 | 13.5% | 5,419 |
| ALTEPLASE | Activase | 12,687 | 2,540 | 20.0% | 2,083 |
| ALECTINIB | ALECENSA | 9,161 | 1,055 | 11.5% | 1,553 |
| VEMURAFENIB | ZELBORAF | 8,562 | 1,040 | 12.1% | 2,368 |
| VISMODEGIB | ERIVEDGE | 8,135 | 864 | 10.6% | 974 |
| DORNASE ALFA | Pulmozyme | 5,438 | 318 | 5.8% | 2,773 |
| POLATUZUMAB VEDOTIN | POLIVY | 4,739 | 908 | 19.2% | 1,517 |
| COBIMETINIB | Cotellic | 4,071 | 527 | 12.9% | 1,895 |
| RISDIPLAM | EVRYSDI | 3,619 | 336 | 9.3% | 719 |
| BALOXAVIR MARBOXIL | Xofluza | 2,010 | 120 | 6.0% | 378 |
| ENTRECTINIB | Rozlytrek | 1,491 | 246 | 16.5% | 316 |
| PRALSETINIB | Gavreto | 1,419 | 226 | 15.9% | 431 |
| TENECTEPLASE | TNKase | 1,319 | 310 | 23.5% | 314 |
| GLOFITAMAB | Columvi | 1,116 | 315 | 28.2% | 492 |
| HYALURONIDASE | Phesgo | 1,107 | 470 | 42.5% | 775 |
| EMICIZUMAB | Hemlibra | 733 | 42 | 5.7% | 159 |
| MOSUNETUZUMAB | Lunsumio Velo | 506 | 96 | 19.0% | 328 |
| FARICIMAB | VABYSMO | 381 | 23 | 6.0% | 98 |
| SATRALIZUMAB | Enspryng | 219 | 16 | 7.3% | 108 |
| INAVOLISIB | Itovebi | 188 | 6 | 3.2% | 60 |
| TRASTUZUMAB EMTANSINE | KADCYLA | 183 | 21 | 11.5% | 119 |